Multi-cohort cross-omics analysis reveals disease mechanisms and therapeutic targets in HTLV-1-associated myelopathy, a neglected retroviral neuroinflammatory disorder.
Van Weyenbergh J, Assone T, Racine I, Menezes S, Gonçalves F, Folgosi V, Marcusso R, Haziot M, Smid J, Dahy F, Gascon M, Paiva A, Galvao-Castro B, Araújo T, Grassi M, Sousa M, Puccioni-Sohler M, Nukui Y, Kashima S, Dierckx T, Twizere JC, Murphy E, Bruhn R, Pannecouque C, Claes S, Vanderlinden E, Schols D, Vercauteren J, Alvarez C, Lopez G, Talledo M, Gotuzzo E, Oliveira A, Cleynen I, Casseb J.
Van Weyenbergh J, et al. Among authors: puccioni sohler m.
Res Sq [Preprint]. 2025 Apr 29:rs.3.rs-5960764. doi: 10.21203/rs.3.rs-5960764/v1.
Res Sq. 2025.
PMID: 40343334
Free PMC article.
Preprint.